comparemela.com

Page 17 - Clay Siegall News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Seagen Inc (SGEN) CEO Clay Siegall on Q1 2022 Results - Earnings Call Transcript

Seagen Inc. (NASDAQ:NASDAQ:SGEN) Q1 2022 Earnings Conference Call April 28, 2022 04:30 PM ET Company Participants Peggy Pinkston - Senior Vice President of Investor Relations Clay Siegall -.

United statesUnited kingdomCory kasimovAndy hsiehPeggy pinkstonJoe catanzaroGena wangAsia pacificAndrew berensSalveen richterGeoff meachamJay olsonClay siegallDaiichi sankyoZhiqiang shuPiper sandler

Juno Therapeutics vets Steve Harr and Hans Bishop on building startups, working with tech, and more

Juno Therapeutics vets Steve Harr and Hans Bishop on building startups, working with tech, and more
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

United statesClay siegallSteve harrRashmi joshiHoward pienDayton kellyHans bishopLife science innovationLife science washington photoJuno therapeuticsSeattle based sana biotechnologyScience innovation northwestLife science washingtonLife science innovation northwest

Seagen to expand, add jobs with new cancer drug factory

BioPharma

United statesClay siegallDrug administrationMerck coDive briefSeattle geneticsFinch therapeutics

Biotech giant Seagen reveals plans for 270K square-foot manufacturing facility near Seattle

Biotech giant Seagen reveals plans for 270K square-foot manufacturing facility near Seattle
geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.

United statesClay siegallEvotec biologicsLyell immunopharmaEuropean unionBristol myers squibbSeagen imagePresident clay siegallPacific northwestJust evotec biologics

Seagen Announces Jury Award in Patent Infringement Case Against Daiichi Sankyo

- Jury Upholds Validity of Asserted Claims of the Patent, Finds Willful Infringement and Issues Past Damages Award of $41.82 Million Seagen to Request Royalty on Future U.S. Sales of Enhertu® Through the Life of the Patent Separate Arbitration Proceedings with Daiichi Sankyo Remain Ongoing with a Decision Expe.

United statesDavid caouetteClay siegallPeggy pinkstonDaiichi sankyoDaiichi sankyo coUs district courtSeagen incTrademark officeExchange commissionEuropean unionCorporate communicationsUpholds validityAsserted claimsFinds willful infringementIssues past damages award

vimarsana © 2020. All Rights Reserved.